Trends of laboratory nonhuman primate licensing in China between 2020 and 2024: A national database analysis

KIZ OpenIR > 科研部门 > 肿瘤生物学（陈策实）

	Trends of laboratory nonhuman primate licensing in China between 2020 and 2024: A national database analysis
	Ma, BX; Yuan, MY; Xiao, WX; Lv, LB
	2026
发表期刊	PLoS One
卷号	21 期号:5
摘要	Nonhuman primates are critical translational models in biomedical research due to their genetic, anatomical, and physiological similarities to humans. China, once a dominant global supplier of captive-bred laboratory primates, has long maintained a national licensure system to govern their production and use. Despite this, the overall scope, spatial distribution, and institutional landscape of licensing activities for laboratory primates in China remain insufficiently characterized, limiting data-driven governance and resource planning. This study conducted a comprehensive retrospective analysis of all laboratory primate licenses issued in China between 2020 and 2024, based on data retrieved from the China Laboratory Animal Licensing Management System (LALMS). In total, 430 licenses were analyzed across production and utilization categories, temporal dynamics, geographical distribution, and institutional ownership. Utilization licenses constituted 85% of the total, while production licenses accounted for 15%. Licensing activity expanded progressively until 2023 before declining sharply in 2024. Among 31 provincial-level administrative divisions in mainland China, 28 were authorized to produce or utilize laboratory primates. Beijing and Jiangsu emerged as primary centers of licensing activity, particularly for utilization. In contrast, production licenses were predominantly concentrated in Guangxi and Yunnan. Utilization licenses exhibited broader geographic distribution than production licenses, although licensing activity was heavily concentrated in East China (31%), North China (22%), and South China (19%). The majority of licenses were held by commercial enterprises (60%), followed by universities (22%) and research institutes (18%). These findings define the temporal and spatial landscape of laboratory primate licensing in China and generate critical data to inform resource allocation, improve regulatory transparency, and promote the responsible and sustainable integration of primate models into biomedical research.
收录类别	SCIE
语种	英语
文献类型	期刊论文
条目标识符	http://ir.kiz.ac.cn/handle/152453/15048
专题	科研部门_肿瘤生物学（陈策实）
推荐引用方式 GB/T 7714	Ma, BX,Yuan, MY,Xiao, WX,et al. Trends of laboratory nonhuman primate licensing in China between 2020 and 2024: A national database analysis[J]. PLoS One,2026,21(5).
APA	Ma, BX,Yuan, MY,Xiao, WX,&Lv, LB.(2026).Trends of laboratory nonhuman primate licensing in China between 2020 and 2024: A national database analysis.PLoS One,21(5).
MLA	Ma, BX,et al."Trends of laboratory nonhuman primate licensing in China between 2020 and 2024: A national database analysis".PLoS One 21.5(2026).

条目包含的文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
2026071303.pdf（820KB）	期刊论文	出版稿	开放获取	CC BY-NC-SA	请求全文